Article Text

PDF
Treating multiple sclerosis with vitamin D
  1. Jeremy Chataway
  1. Correspondence to Dr Jeremy Chataway, National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust; Department of Neuroinflammation, Institute of Neurology, University College London, Queen Square, London WC1N 3BG, UK; jeremy.chataway{at}uclh.nhs.uk

Statistics from Altmetric.com

For neurologists, tracking down the cause of multiple sclerosis (MS) has echoes of the search for the elusive Higgs boson. At times close, at times far. Does vitamin D give us a 125 GeV signature? What evidence do we have, and what evidence do we need, for a central role of vitamin D in the pathogenesis of MS? If we divide the current information along traditional observational and interventional lines, then another track may have been visualised. Soilu-Hänninen1 and colleagues asked what would happen if vitamin D (20 000 IU vitamin D3 per week) was added to standard disease modifying …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles